US Patent Issued to St. Jude Children's Research Hospital on Sept. 8 for "Method and kit for determining benefit of chemotherapy" (Tennessee Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,405, issued on Sept. 8, was assigned to St. Jude Children's Research Hospital Inc. (Memphis, Tenn.).

"Method and kit for determining benefit of chemotherapy" was invented by Jun J. Yang (Memphis, Tenn.) and Jiyang Yu (Memphis, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Nucleic acid- and protein-based methods for identifying a patient sensitive to treatment with a tyrosine kinase inhibitor are provided, as is a method for treating a subject with a T-lineage hematological malignancy. Specifically, the method comprising determining activity levels of LCK nucleic acid or protein in a biological sample from a patient with a T-lineage hematologi...